Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer. - Wikidata - wikimedia - TriplyDB

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

http://www.wikidata.org/entity/Q37018096

about

Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.

P2860

Q38431186-CCB07B64-317B-4D30-878C-ABC231D684AA Q38621653-112D003D-CDD6-460A-A833-48BA2142E201

P2860

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

http://www.wikidata.org/entity/Q37018096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@en

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@nl

type

label

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@en

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@nl

prefLabel

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@en

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@nl

P1433

Q37018096-3F8F55F3-80EE-41FD-9CD7-99A375905DB7

P1476

Q37018096-6CC3F864-B608-4ED0-AC9C-E3E0422DADB8

P2093

Q37018096-0B03E192-7480-4E28-B7E3-402F700AA472

Q37018096-3222F256-B00C-4735-BDA5-4B652EEA0A28

Q37018096-6FEBCB2C-9844-4824-9819-89C699B7B094

Q37018096-EEB30EDA-4311-4E25-9FB6-8D0C4A1F4A78

P2860

Q37018096-02506FE5-1A93-4680-8EAA-AEE7B338FA4B

Q37018096-1D51AB60-F6F2-4C6C-B64F-4C65AADAE5A8

Q37018096-2819B539-7574-4397-8EE1-C60A37388463

Q37018096-2E5FDD30-F807-445D-BB79-2BB64D66F046

Q37018096-2EAF09AC-6A56-41C1-A513-55830A121E1C

Q37018096-32506D21-2A03-4647-96F7-D4E74C3D45E5

Q37018096-3B7CBD8A-8548-42B8-8580-2507A18DFECB

Q37018096-40FE93FC-6F42-4430-B603-CFD8BB2190A0

Q37018096-427FFD86-D5CC-4961-A61C-C55C39CA8B4F

Q37018096-449830BD-CECE-4AFB-8352-A35C8E72000A

P2888

Q37018096-24E68A39-CF5A-48D0-AE91-CB385793397C

P304

Q37018096-5FF1D9C3-AFD1-4132-9291-9A141F30ADF4

P31

Q37018096-2C96FAF2-3CD4-4B55-A400-C6B00F3270F1

P356

Q37018096-DC18D44B-08D9-4E2E-9A7F-104D3A1A3AA9

P433

Q37018096-AD8DF9EF-A9E8-4AA4-888D-E795BE332C34

P478

Q37018096-76580132-D09A-41A1-8062-E98E9EB9BA76

P577

Q37018096-1B708C63-D0DE-41B8-8B61-5874DEC0B56A

P6179

Q37018096-AD2B5AD2-6DC0-445B-BAA5-CD8A7FAB85EF

P698

Q37018096-B7F7E40C-97D1-4908-B8E5-B477381B70C5

P921

Q37018096-6DF9A258-2924-4947-B914-BFFA8258A9DF

P932

Q37018096-F0BB49B5-092D-4B27-9255-D9135B419C30

P356

S13048-016-0244-9

P1433

Journal of Ovarian Research

P1476

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.

@en

P2093

Jun Li

http://www.w3.org/2001/XMLSchema#string

Liang-Dong Li

http://www.w3.org/2001/XMLSchema#string

Xin Lu

http://www.w3.org/2001/XMLSchema#string

Yang Bai

http://www.w3.org/2001/XMLSchema#string

P2860

DNA T OPOISOMERASES : Structure, Function, and Mechanism

Cellular roles of dna topoisomerases: a molecular perspective

Targeting DNA topoisomerase II in cancer chemotherapy

Nonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analog

The Bloom's syndrome gene product interacts with topoisomerase III

ONCOMINE: a cancer microarray database and integrated data-mining platform

DNA topoisomerases and their poisoning by anticancer and antibacterial drugs

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment

Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans

P2888

s13048-016-0244-9

P304

35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13048-016-0244-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047538628

http://www.w3.org/2001/XMLSchema#string

P698

27315793

http://www.w3.org/2001/XMLSchema#string

P921

P932

4912764

http://www.w3.org/2001/XMLSchema#string